We selected Ewing sarcoma, the second most common pediatric bone cancer, for these experiments because it is driven by the disordered oncogenic fusion protein EWS-FLI1 and serves as a paradigm for the role of IDRs in gene regulation23,24. This evidence concerns the gene FLI1 and bone neoplasm.